Cryoport Inc (NASDAQ:CYRX)

7.33
Delayed Data
As of Apr 20
 -0.16 / -2.14%
Today’s Change
2.27
Today|||52-Week Range
10.40
-14.67%
Year-to-Date
SECTOR
Process Industries
INDUSTRY
Containers/Packaging
MARKET CAP
$272.6M

Company Description

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Lake Forest, CA.

Contact Information

CryoPort, Inc.
17305 Daimler Street
Irvine California 92614
P:(949) 470-2300
Investor Relations:

Employees

Shareholders

Mutual fund holders12.18%
Other institutional11.54%
Individual stakeholders1.97%

Top Executives

Jerrell W. SheltonChairman, President & Chief Executive Officer
Robert S. StefanovichChief Financial Officer, Secretary & Treasurer
Bret BollingerChief Technology Officer
Mark W. SawickiChief Commercial Officer
Colin CoffuaVice President-Strategic Accounts